As of April 16, 2025, Sana Biotechnology (SANA) has a market cap of $0.38 billion USD. According to our data, Sana Biotechnology is ranked No.6246 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.38 B |
5.11%
|
Dec 31, 2024 | $0.36 B |
-60.05%
|
Dec 29, 2023 | $0.91 B |
3.29%
|
Dec 30, 2022 | $0.88 B |
-74.48%
|
Dec 31, 2021 | $3.46 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Allogene Therapeutics
ALLO
|
$0.32 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Replimune
REPL
|
$0.59 B |
0.000 M
|
![]() USA
|
![]() Atara Biotherapeutics
ATRA
|
$35.04 M |
-0.000 M
|
![]() USA
|
Market Cap | = | SANA Stock Price | * | SANA Shares Outstanding |
= | $1.70 | * | 0.23 B | |
= | $0.38 B |